Le Zhao

Person

Wilmington, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fused pyrimidine derivatives as A2A/A2B inhibitors
- Patent number 11,873,304
- Issue date Jan 16, 2024
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
- Patent number 11,673,894
- Issue date Jun 13, 2023
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro compounds as inhibitors of KRAS
- Patent number 11,530,218
- Issue date Dec 20, 2022
- Incyte Corporation
- Le Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrimidine derivatives as A2A / A2B inhibitors
- Patent number 11,168,089
- Issue date Nov 9, 2021
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20250034153
- Publication date Jan 30, 2025
- INCYTE CORPORATION
- Heeoon Han
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20240368152
- Publication date Nov 7, 2024
- INCYTE CORPORATION
- Qinda YE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20230357255
- Publication date Nov 9, 2023
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR
- Publication number 20230226040
- Publication date Jul 20, 2023
- INCYTE CORPORATION
- Alejandro Amador Arjona
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIRO COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230192696
- Publication date Jun 22, 2023
- INCYTE CORPORATION
- Le Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230144051
- Publication date May 11, 2023
- INCYTE CORPORATION
- Qinda YE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20230124485
- Publication date Apr 20, 2023
- INCYTE CORPORATION
- Heeoon Han
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230056631
- Publication date Feb 23, 2023
- INCYTE CORPORATION
- Pei Gan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20210269434
- Publication date Sep 2, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED PYRIMIDINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20210261555
- Publication date Aug 26, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIRO COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20210230162
- Publication date Jul 29, 2021
- INCYTE CORPORATION
- Le Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20210061809
- Publication date Mar 4, 2021
- INCYTE CORPORATION
- Heeoon Han
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRIMIDINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20190375752
- Publication date Dec 12, 2019
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Fused pyrimidine derivatives as A2A/A2B inhibitors

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Spiro compounds as inhibitors of KRAS

Fused pyrimidine derivatives as A2A / A2B inhibitors

Patents Applicationslast 30 patents

TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR

SPIRO COMPOUNDS AS INHIBITORS OF KRAS

QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS

TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

FUSED PYRIMIDINE DERIVATIVES AS A2A / A2B INHIBITORS

SPIRO COMPOUNDS AS INHIBITORS OF KRAS

TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

FUSED PYRIMIDINE DERIVATIVES AS A2A / A2B INHIBITORS